U. Fink

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

Florian Lordick, Katja Ott, Bernd‐Joachim Krause et al. · The Lancet Oncology · 2007 · 803 citations

Esophagus, Oesophagogastric Junction, Esophageal Cancer +9

Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy

Karen Becker, James Mueller, Christoph Schulmacher et al. · Cancer · 2003 · 800 citations · Full text

Surgical Oncology, Esophageal Cancer, Cancer Management +18

Prediction of Response to Preoperative Chemotherapy in Adenocarcinomas of the Esophagogastric Junction by Metabolic Imaging

Wolfgang Weber, Katja Ott, Karen Becker et al. · Journal of Clinical Oncology · 2001 · 704 citations

Histologic Tumor Type Is an Independent Prognostic Parameter in Esophageal Cancer: Lessons From More Than 1,000 Consecutive Resections at a Single Center in the Western World

J. R. Siewert, H. J. Stein, Marcus Feith et al. · Annals of Surgery · 2001 · 527 citations · Full text

Metabolic Imaging Predicts Response, Survival, and Recurrence in Adenocarcinomas of the Esophagogastric Junction

Katja Ott, Wolfgang Weber, Florian Lordick et al. · Journal of Clinical Oncology · 2006 · 461 citations